Cargando…
Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1
Glutaric acidemia type 1 (GA1) is a neurotoxic metabolic disorder due to glutaryl-CoA dehydrogenase (GCDH) deficiency. The high number of missense variants associated with the disease and their impact on GCDH activity suggest that disturbed protein conformation can affect the biochemical phenotype....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487539/ https://www.ncbi.nlm.nih.gov/pubmed/37685964 http://dx.doi.org/10.3390/ijms241713158 |
_version_ | 1785103267580084224 |
---|---|
author | Barroso, Madalena Gertzen, Marcus Puchwein-Schwepcke, Alexandra F. Preisler, Heike Sturm, Andreas Reiss, Dunja D. Danecka, Marta K. Muntau, Ania C. Gersting, Søren W. |
author_facet | Barroso, Madalena Gertzen, Marcus Puchwein-Schwepcke, Alexandra F. Preisler, Heike Sturm, Andreas Reiss, Dunja D. Danecka, Marta K. Muntau, Ania C. Gersting, Søren W. |
author_sort | Barroso, Madalena |
collection | PubMed |
description | Glutaric acidemia type 1 (GA1) is a neurotoxic metabolic disorder due to glutaryl-CoA dehydrogenase (GCDH) deficiency. The high number of missense variants associated with the disease and their impact on GCDH activity suggest that disturbed protein conformation can affect the biochemical phenotype. We aimed to elucidate the molecular basis of protein loss of function in GA1 by performing a parallel analysis in a large panel of GCDH missense variants using different biochemical and biophysical methodologies. Thirteen GCDH variants were investigated in regard to protein stability, hydrophobicity, oligomerization, aggregation, and activity. An altered oligomerization, loss of protein stability and solubility, as well as an augmented susceptibility to aggregation were observed. GA1 variants led to a loss of enzymatic activity, particularly when present at the N-terminal domain. The reduced cellular activity was associated with loss of tetramerization. Our results also suggest a correlation between variant sequence location and cellular protein stability (p < 0.05), with a more pronounced loss of protein observed with variant proximity to the N-terminus. The broad panel of variant-mediated conformational changes of the GCDH protein supports the classification of GA1 as a protein-misfolding disorder. This work supports research toward new therapeutic strategies that target this molecular disease phenotype. |
format | Online Article Text |
id | pubmed-10487539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104875392023-09-09 Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 Barroso, Madalena Gertzen, Marcus Puchwein-Schwepcke, Alexandra F. Preisler, Heike Sturm, Andreas Reiss, Dunja D. Danecka, Marta K. Muntau, Ania C. Gersting, Søren W. Int J Mol Sci Article Glutaric acidemia type 1 (GA1) is a neurotoxic metabolic disorder due to glutaryl-CoA dehydrogenase (GCDH) deficiency. The high number of missense variants associated with the disease and their impact on GCDH activity suggest that disturbed protein conformation can affect the biochemical phenotype. We aimed to elucidate the molecular basis of protein loss of function in GA1 by performing a parallel analysis in a large panel of GCDH missense variants using different biochemical and biophysical methodologies. Thirteen GCDH variants were investigated in regard to protein stability, hydrophobicity, oligomerization, aggregation, and activity. An altered oligomerization, loss of protein stability and solubility, as well as an augmented susceptibility to aggregation were observed. GA1 variants led to a loss of enzymatic activity, particularly when present at the N-terminal domain. The reduced cellular activity was associated with loss of tetramerization. Our results also suggest a correlation between variant sequence location and cellular protein stability (p < 0.05), with a more pronounced loss of protein observed with variant proximity to the N-terminus. The broad panel of variant-mediated conformational changes of the GCDH protein supports the classification of GA1 as a protein-misfolding disorder. This work supports research toward new therapeutic strategies that target this molecular disease phenotype. MDPI 2023-08-24 /pmc/articles/PMC10487539/ /pubmed/37685964 http://dx.doi.org/10.3390/ijms241713158 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Barroso, Madalena Gertzen, Marcus Puchwein-Schwepcke, Alexandra F. Preisler, Heike Sturm, Andreas Reiss, Dunja D. Danecka, Marta K. Muntau, Ania C. Gersting, Søren W. Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 |
title | Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 |
title_full | Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 |
title_fullStr | Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 |
title_full_unstemmed | Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 |
title_short | Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1 |
title_sort | glutaryl-coa dehydrogenase misfolding in glutaric acidemia type 1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487539/ https://www.ncbi.nlm.nih.gov/pubmed/37685964 http://dx.doi.org/10.3390/ijms241713158 |
work_keys_str_mv | AT barrosomadalena glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT gertzenmarcus glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT puchweinschwepckealexandraf glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT preislerheike glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT sturmandreas glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT reissdunjad glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT daneckamartak glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT muntauaniac glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 AT gerstingsørenw glutarylcoadehydrogenasemisfoldinginglutaricacidemiatype1 |